Search

Displaying results 6511 - 6520 of 9333 in total
  1. Drug

    Fenaperone

    go.drugbank.com/drugs/DB21281
    Experimental

    The usage of the INN stem '-perone' in the name indicates that Fenaperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  2. Drug

    Metrenperone

    go.drugbank.com/drugs/DB21312
    Experimental

    The usage of the INN stem '-perone' in the name indicates that Metrenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  3. Drug

    Acefylline clofibrol

    go.drugbank.com/drugs/DB21353
    Experimental

    The usage of the INN stem '-fylline' in the name indicates that Acefylline clofibrol is a N-methylated xanthine derivative. Acefylline clofibrol has a monoisotopic molecular weight of 420.12 Da.

  4. Drug

    Sofnobrutinib

    go.drugbank.com/drugs/DB21626
    Experimental

    The usage of the INN stem '-brutinib' in the name indicates that Sofnobrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  5. Drug

    Lacutoclax

    go.drugbank.com/drugs/DB21657
    Investigational

    The usage of the INN stem '-toclax' in the name indicates that Lacutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor. Lacutoclax has a monoisotopic molecular weight of 922.36 Da.

  6. Drug

    Vilzemetkib

    go.drugbank.com/drugs/DB21704
    Experimental

    The usage of the INN stem '-metkib' in the name indicates that Vilzemetkib is a MET (mesenchymal epithelial transition factor) kinase inhibitor.

  7. Drug

    Recombinant human plasma gelsolin

    go.drugbank.com/drugs/DB15746
    Investigational

    Plasma gelsolin (pGSN) is a protein found in the blood of healthy individuals which scavenges compounds left over from damaged tissues.

  8. Drug

    NS-398

    go.drugbank.com/drugs/DB14060
    Experimental

    It was developed as part of the mechanistic study of the cyclooxygenases.

  9. Drug

    SR 140333

    go.drugbank.com/drugs/DB05790
    Experimental

    SR 140333 is tachykinin antagonist which has potential to treat diarrhoea due to food allergy or inflammatory bowel disease.

  10. Drug

    Psilocybin

    go.drugbank.com/drugs/DB11664
    Investigational

    Psilocybin has been investigated for the treatment of Anxiety and Stage IV Melanoma. In November, 2019, it was granted Breakthrough Therapy status by the FDA.